.Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A06A_DrugsForConstipation.A06AG06_Oil.Oil .Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A06A_DrugsForConstipation.A06AG06_Oil.Oil| name: | Oil |
| ATC code: | A06AG06 | route: | oral |
| n-compartments | 1 |
Oil with ATC code A06AG06 refers to mineral oil or liquid paraffin, a laxative used to treat constipation. It acts as a lubricant to ease the passage of stool. However, its use has significantly decreased due to potential adverse effects, including lipoid pneumonia, and it is not generally recommended in current clinical practice.
No pharmacokinetic parameters for mineral oil as a laxative in humans are available in current literature; its absorption is negligible as it largely remains in the gastrointestinal tract.
Gamble, LJ, et al., & Wakshlag, JJ (2018). Pharmacokinetics, Safety, and Clinical Efficacy of Cannabidiol Treatment in Osteoarthritic Dogs. Frontiers in veterinary science 5 165–None. DOI:10.3389/fvets.2018.00165 PUBMED:https://pubmed.ncbi.nlm.nih.gov/30083539
Sánchez de Medina, A, et al., & Sánchez de Medina, V (2023). Pharmacokinetics and oral bioavailability of cannabidiol in horses after intravenous and oral administration with oil and micellar formulations. Equine veterinary journal 55(6) 1094–1103. DOI:10.1111/evj.13923 PUBMED:https://pubmed.ncbi.nlm.nih.gov/36624043
Adiwidjaja, J, & Sasongko, L (2021). Effect of Nigella sativa oil on pharmacokinetics and pharmacodynamics of gliclazide in rats. Biopharmaceutics & drug disposition 42(8) 359–371. DOI:10.1002/bdd.2300 PUBMED:https://pubmed.ncbi.nlm.nih.gov/34327715